What Is Tirzepatide? Dual GIP/GLP-1 and Why Should I Use It Twincretin Explained (2026)

What is tirzepatide? Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist—often called a twincretin—that mimics two incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea in adults with obesity, this once-weekly peptide is studied for blood sugar control, appetite regulation, gastric emptying, and body-weight reduction.
This educational video from videos.findpeptides.org explains how tirzepatide works at the receptor level, why dual agonism differs from single GLP-1 drugs like semaglutide (Ozempic, Wegovy), and how SURPASS and SURMOUNT trial data shaped interest in the molecule. You will learn the difference between branded tirzepatide and research-grade peptide material, key terms (incretin mimetic, LY3298176, dual agonist), and how tirzepatide compares with semaglutide and newer triple agonists such as retatrutide.
Watch to understand mechanism of action, FDA-approved uses versus research context, common search questions (tirzepatide vs semaglutide, how tirzepatide works, Mounjaro vs Zepbound), and why peptide structure and purity matter in laboratory research. This is educational content only—not medical advice. Research peptides are not for human consumption. Explore more peptide explainers at FindPeptides.org.

#tirzepatide #whatistirzepatide #mounjaro #zepbound #glp1 #gip #twincretin #dualagonist #semaglutide #ozempic #wegovy #retatrutide #weightlosspeptide #type2diabetes #incretin #peptideeducation #peptideresearch #researchpeptides #findpeptides #glp1agonist #howtirzepatideworks #mounjarovszepbound #tirzepatidevssemaglutide #metabolichealth #obesityresearch #surmount #surpass #peptidevideo #labresearch #notformedicaladvice